Patients With ND AML Unfit for Intensive Chemotherapy: Tailoring Treatment

Keeping Current
31/03/2020 20 min
Patients With ND AML Unfit for Intensive Chemotherapy: Tailoring Treatment

Listen "Patients With ND AML Unfit for Intensive Chemotherapy: Tailoring Treatment"

Descargar episodio Ver en sitio original

Episode Synopsis

Drs Wei and DiNardo discuss the treatment landscape for patients with ND AML who are ineligible for intensive chemotherapy. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/927635?src=mkm_podcast_addon_927635

More episodes of the podcast Keeping Current

The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology 05/01/2026
Achieving Brain Health in Epilepsy: What Can Clinicians Do? 05/01/2026
Patient Case Challenge: How Would You Manage This Patient With MASH? 31/12/2025
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies 24/12/2025
Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences 19/12/2025
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy 18/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies 12/12/2025
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies 10/12/2025
Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care 09/12/2025
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA